Pimasertib

An orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity. Pimasertib selectively binds to and inhibits the activity of MEK1/2, preventing the activation of MEK1/2-dependent effector proteins and transcription factors, which may result in the inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK1/2 (MAP2K1/K2) are dual-specificity threonine/tyrosine kinases that play key roles in the activation of the RAS/RAF/MEK/ERK pathway and are often upregulated in a variety of tumor cell types. (NCI Thesaurus)

YOU MAY ALSO LIKE

PIM2 wt Allele

Human PIM2 wild-type allele is located in the vicinity of Xp11.23 and is approximately 6 kb in length. This allele, which encodes…

PIM2 Gene

This gene plays a role in protein phosphorylation, cell proliferation and the regulation of apoptosis.

PIM1 wt Allele

Human PIM1 wild-type allele is located in the vicinity of 6p21.2 and is approximately 5 kb in length. This allele, which encodes…

PIM1 Gene

This gene is involved in apoptosis, cell cycle regulation and signal transduction.

PIM Kinase Inhibitor SGI-1776

A small-molecule pan-PIM protein kinase inhibitor with potential antineoplastic activity. PIM kinase inhibitor SGI-1776 binds to and inhibits the activities of PIM-1,…

PIM Kinase Inhibitor LGH447

An orally available pan-PIM protein kinase inhibitor with potential antineoplastic activity. PIM kinase inhibitor LGH447 binds to and inhibits the activities of…